LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset (ID:20237)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MDA-MB-231 | Withaferin A | 0.12 | uM | LJP6 | 2 | G17 | 72 | hr | 868 | 3591 | 3486 | 1.0300 | 1.0400 |
MDA-MB-231 | Withaferin A | 0.12 | uM | LJP6 | 3 | G17 | 72 | hr | 868 | 3417 | 3486 | 0.9801 | 0.9735 |
MDA-MB-231 | WYE-125132 | 0.12 | uM | LJP6 | 1 | L11 | 72 | hr | 868 | 1859 | 3486 | 0.5332 | 0.3785 |
MDA-MB-231 | WYE-125132 | 0.12 | uM | LJP6 | 2 | L11 | 72 | hr | 868 | 2147 | 3486 | 0.6158 | 0.4884 |
MDA-MB-231 | WYE-125132 | 0.12 | uM | LJP6 | 3 | L11 | 72 | hr | 868 | 2219 | 3486 | 0.6365 | 0.5159 |
MDA-MB-231 | WZ3105 | 0.12 | uM | LJP5 | 1 | D23 | 72 | hr | 868 | 683 | 3486 | 0.1959 | -0.0707 |
MDA-MB-231 | WZ3105 | 0.12 | uM | LJP5 | 2 | D23 | 72 | hr | 868 | 761 | 3486 | 0.2183 | -0.0409 |
MDA-MB-231 | WZ3105 | 0.12 | uM | LJP5 | 3 | D23 | 72 | hr | 868 | 706 | 3486 | 0.2025 | -0.0619 |
MDA-MB-231 | XMD11-50 | 0.12 | uM | LJP6 | 1 | P11 | 72 | hr | 868 | 2641 | 3486 | 0.7575 | 0.6771 |
MDA-MB-231 | XMD11-50 | 0.12 | uM | LJP6 | 2 | P11 | 72 | hr | 868 | 3280 | 3486 | 0.9408 | 0.9212 |
MDA-MB-231 | XMD11-50 | 0.12 | uM | LJP6 | 3 | P11 | 72 | hr | 868 | 2809 | 3486 | 0.8057 | 0.7413 |
MDA-MB-231 | Y39983 | 0.12 | uM | LJP6 | 1 | P05 | 72 | hr | 868 | 2677 | 3486 | 0.7678 | 0.6909 |
MDA-MB-231 | Y39983 | 0.12 | uM | LJP6 | 2 | P05 | 72 | hr | 868 | 3417 | 3486 | 0.9801 | 0.9735 |
MDA-MB-231 | Y39983 | 0.12 | uM | LJP6 | 3 | P05 | 72 | hr | 868 | 3198 | 3486 | 0.9173 | 0.8899 |
MDA-MB-231 | YM 201636 | 0.12 | uM | LJP5 | 1 | N11 | 72 | hr | 868 | 2973 | 3486 | 0.8527 | 0.8039 |
MDA-MB-231 | YM 201636 | 0.12 | uM | LJP5 | 2 | N11 | 72 | hr | 868 | 3809 | 3486 | 1.0925 | 1.1232 |
MDA-MB-231 | YM 201636 | 0.12 | uM | LJP5 | 3 | N11 | 72 | hr | 868 | 3185 | 3486 | 0.9136 | 0.8849 |
MDA-MB-231 | ZSTK474 | 0.12 | uM | LJP6 | 1 | M17 | 72 | hr | 868 | 3108 | 3486 | 0.8915 | 0.8555 |
MDA-MB-231 | ZSTK474 | 0.12 | uM | LJP6 | 2 | M17 | 72 | hr | 868 | 3246 | 3486 | 0.9311 | 0.9082 |
MDA-MB-231 | ZSTK474 | 0.12 | uM | LJP6 | 3 | M17 | 72 | hr | 868 | 3054 | 3486 | 0.8760 | 0.8349 |
MDA-MB-231 | Afatinib | 0.37 | uM | LJP6 | 1 | G22 | 72 | hr | 868 | 2813 | 3486 | 0.8069 | 0.7428 |
MDA-MB-231 | Afatinib | 0.37 | uM | LJP6 | 2 | G22 | 72 | hr | 868 | 3027 | 3486 | 0.8682 | 0.8245 |
MDA-MB-231 | Afatinib | 0.37 | uM | LJP6 | 3 | G22 | 72 | hr | 868 | 2482 | 3486 | 0.7119 | 0.6164 |
MDA-MB-231 | Sigma A6730 | 0.37 | uM | LJP5 | 1 | B22 | 72 | hr | 868 | 2938 | 3486 | 0.8427 | 0.7906 |
MDA-MB-231 | Sigma A6730 | 0.37 | uM | LJP5 | 2 | B22 | 72 | hr | 868 | 3031 | 3486 | 0.8694 | 0.8261 |